Diskussionsleiter: A. El-Armouche (Dresden), S. Massberg (München)
| (P674) | Predictive value of macrophage migration inhibitory factor (MIF) in heart failure with preserved ejection fraction (HFpEF) | |
| G. L. Alatzides, M. Papathanasiou, M. Heisler, J. Pohl, T. Rassaf, P. Lüdike (Essen) | ||
| (P675) | Comparison of deep sedation with general anesthesia in patients undergoing percutaneous mitral valve repair (PMVR) | |
| M. Ulrich, J. Patzelt, H. Magunia, R. J. Sauter, M. Droppa, R. Jorbenadze, A. S. Becker, T. Walker, R. S. von Bardeleben, C. Grasshoff, P. Rosenberger, M. Gawaz, P. Seizer, H. Langer (Tübingen, Mainz) | ||
| (P676) | Requirement of CaM Kinase IIδ for hyperglycemia in a mouse model of type 2 diabetes but no requirement of hyperglycemia for diabetic nephropathy | |
| J. Chen, S. Katz, M. Hagenmüller, M. Kronlage, J. Morgenstern, T. Fleming, H.-J. Gröne, H.-P. Hammes, J. Backs (Heidelberg, Mannheim) | ||
| (P677) | Purinergic receptor Y2 (P2Y2) deficiency protects from metabolic syndrome | |
| P. Albrecht, J. Merz, C. Bode, A. Zirlik, P. Stachon (Freiburg im Breisgau) |